Multiple Choice

A family health team is reviewing recent guidelines for dyslipidemia and cardiovascular risks. Physician colleagues ask the pharmacist for information on the recommendations for monitoring patients in various categories. Which of the following is the primary assessment tool recommended to quantify a patient’s 10-year risk for total cardiovascular disease?